New medicines faster
Precision Neuropharmacology
Allaysis LLC is a virtual pharmaceutical company advancing evidence-based therapies for complex neurological conditions, beginning with intravenous baclofen for severe spasticity management.
Our Mission
Allaysis LLC was founded on the belief that rigorous pharmaceutical science and patient-centered thinking are inseparable. We operate as a virtual company, lean by design and deep in expertise, partnering with world-class academic and clinical institutions to move promising therapies from concept to clinic.
Our approach is built on orthogonal evidence: combining pharmacokinetic modeling, formulation science, and clinical need assessment before committing to a development path. We don’t follow trends. We follow data.
Our collaboration with the University of Minnesota positions us at the leading edge of CNS pharmacology, with a shared commitment to translating bench science into treatments that make a measurable difference in patients’ lives.
Programs
Focused development programs targeting conditions with significant unmet medical need and compelling pharmacological rationale.
Get in Touch
We welcome conversations with academic collaborators, clinical investigators, potential commercial partners, and investors who share our commitment to advancing neuropharmacology.